- Report
- March 2024
- 185 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- April 2024
- 382 Pages
Global
From €5269EUR$5,450USD£4,526GBP
- Report
- September 2023
- 120 Pages
North America
From €5752EUR$5,950USD£4,941GBP
- Report
- April 2022
- 264 Pages
Global
From €5801EUR$6,000USD£4,983GBP
- Report
- April 2023
- 160 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- March 2023
- 362 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- September 2021
- 273 Pages
Global
From €5963EUR$6,168USD£5,122GBP
The Antibiotic Susceptibility Test (AST) market is a subset of the Infectious Disease Testing market. ASTs are used to determine the effectiveness of antibiotics against a particular bacterial strain. This helps clinicians select the most appropriate antibiotic for a given infection. ASTs are typically performed on bacterial cultures grown in the laboratory, and the results are used to guide the selection of antibiotics for treatment. ASTs are used to detect resistance to antibiotics, which is becoming increasingly common due to the overuse of antibiotics.
ASTs are used in both clinical and research settings. In clinical settings, ASTs are used to diagnose and treat bacterial infections. In research settings, ASTs are used to study the mechanisms of antibiotic resistance and to develop new antibiotics.
Companies in the AST market include bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Merck, and Roche. Show Less Read more